FGWP
MRK icon

Founders Grove Wealth Partners’s Merck MRK Stock Holding History

Founders Grove Wealth Partners’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$518K Buy
4,309
+197
+5% +$22.7K 0.12% 98
2025
Q4 		$433K Buy
4,112
+533
+15% +$50K 0.1% 106
2025
Q3 		$300K Buy
3,579
+388
+12% +$32K 0.07% 118
2025
Q2 		$253K Sell
3,191
-175
-5% -$13.9K 0.06% 116
2025
Q1 		$302K Buy
3,366
+79
+2% +$7.38K 0.08% 101
2024
Q4 		$327K Buy
+3,287
New +$339K 0.09% 98

Other funds holding MRK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Founders Grove Wealth Partners's MRK Position: Q1 2026 in Review

Founders Grove Wealth Partners increased its Merck (MRK) stake by 4.8% in Q1 2026, buying an estimated $22.7K and bringing the position to 4,309 shares worth $518K. The position accounts for 0.12% of the portfolio, ranked #98.

Founders Grove Wealth Partners first reported a position in MRK in Q4 2024 and has held it in 6 quarters since. 3,777 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Founders Grove Wealth Partners held 4,309 shares of Merck worth $518K as of Q1 2026.
  • Founders Grove Wealth Partners bought 197 Merck shares in Q1 2026, an estimated $22.7K.
  • Merck made up 0.12% of Founders Grove Wealth Partners's portfolio in Q1 2026, its #98 holding.
  • Founders Grove Wealth Partners first reported a position in Merck in Q4 2024 and has held it in 6 quarters since.
  • 3,777 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Founders Grove Wealth Partners's 13F filing for Q1 2026, filed 15 Apr 2026.